0
Articles   |    
Primary Cementless Total Hip Arthroplasty in Octogenarians Two to Eleven-Year Follow-up
Kjell S. Keisu, MD; Fabio Orozco, MD; Peter F. Sharkey, MD; William J. Hozack, MD; Richard H. Rothman, MD, PhD
View Disclosures and Other Information
Investigation performed at the Rothman Institute, Philadelphia, Pennsylvania
Kjell S. Keisu, MD Fabio Orozco, MD Peter F. Sharkey, MD William J. Hozack, MD Richard H. Rothman, MD, PhD Rothman Institute, 925 Chestnut Street, 5th Floor, Philadelphia, PA 19107-4216
Although none of the authors has received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article, benefits have been or will be received but are directed solely to a research fund, foundation, educational institution, or other nonprofit organization with which one or more of the authors is associated. Funds were received in total or partial support of the research or clinical study presented in this article. The funding source was Biomet, Incorporated.

The Journal of Bone & Joint Surgery.  2001; 83:359-359 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Abstract

Background: Cementless total hip arthroplasty is an accepted alternative to total hip arthroplasty with cement in younger patients, but it remains controversial for elderly patients. The purpose of this study was to evaluate the clinical and radiographic outcomes of cementless total hip arthroplasty with use of a proximally coated stem in patients who were at least eighty years of age at the time of the operation.

Methods: One hundred and twenty-three cementless total hip replacements were performed for the treatment of osteoarthritis in 114 patients between the ages of eighty and eighty-nine years. Seven patients (eight hips) died within two years after the surgery, seventeen patients (eighteen hips) died more than two years postoperatively but were not followed for at least two years, and five hips were lost to follow-up; this left ninety-two hips in eighty-six patients for review. The mean duration of follow-up was five years (range, two to eleven years). For the clinical evaluation, the Charnley modification of the Merle d’Aubigné and Postel scale was used. In addition, preoperative and postoperative Harris hip scores were available for sixty-nine hips. Seventy-eight hips were followed radiographically for two years or more. The focus of the radiographic evaluation was the status of the fixation of the femoral and acetabular components as well as cup wear.

Results: Perioperative medical complications occurred in association with 24% (thirty) of the 123 operations, but there were no deaths. The mean Charnley scores for pain and function for the ninety-two hips that were followed clinically for at least two years improved by 3.0 and 1.4 points, respectively. The sixty-nine hips for which preoperative and postoperative Harris hip scores were available had a mean improvement of 42 points, with a mean score of 82 points at the last follow-up evaluation. Mild thigh pain was present in four patients, but it did not limit their activity. There were no femoral component revisions. All of the femoral components were radiographically stable and had bone ingrowth. No acetabular component failed by loosening, but 41% (thirty) of the seventy-three hips with radiographs available for measurement of wear showed polyethylene wear. Of the seventy-eight cups that were followed radiographically for two years or more, 4% (three) were associated with lysis, but none had been revised.

Conclusions: Cementless fixation in the elderly is safe, effective, and durable at the time of two to eleven-year follow-up.

Figures in this Article
    Total hip arthroplasty with cement for patients older than eighty years of age has proven efficacy1-5. Cementless total hip arthroplasty is an accepted alternative in younger patients. Uncertainties regarding stem fixation, pain relief, demand on the implant, and cost are the basis for a widely held belief that the use of uncemented porous ingrowth total hip prostheses should be restricted to physiologically young patients6-9. However, because of the ever-increasing longevity and activity of the elderly, the value of a cementless implant in this population should not be dismissed. Additionally, fat embolism is potentially a serious problem for the elderly ­because of their lower level of physical reserves, and it could be partially prevented by the use of cementless implants10-14. Fat embolism has been most closely associated with total hip arthroplasties with cement, but it has also been seen with procedures in which cement was not used12,15,16. Elderly patients, who may be more fragile than younger patients, also may benefit from a reduction in surgical time. Eliminating the time ­required for the cement to harden can reduce the duration of the procedure by approximately twenty minutes. In this study, we reviewed the experience at a single institution in which cementless primary total hip arthroplasties were performed in octogenarians and the results were followed for a two to eleven-year period.
     
    Anchor for JumpAnchor for JumpTABLE I:  Demographic Characteristics
    No. of hips92
    No. of patients86
    Mean duration of follow-up (range) (yr)?5 (2-11)
    Mean age (range) (yr)83 (80-89)
    Mean weight (range) (kg)68 (49-109)
    Gender (M/F) (no. of hips)32/60
    Initial diagnosis (no. of hips)
    Osteoarthritis91
    Avascular necrosis?1
    Charnley class (% of hips)
    A54
    B39
    C?7
    Between September 1987 and December 1993, a total of 2237 primary cementless total hip arthroplasties were performed for the treatment of osteoarthritis at our institution by the two senior authors (R.H.R. and W.J.H.). One hundred and twenty-three (5%) of these procedures were performed in 114 patients between the ages of eighty and eighty-nine years. To provide a more complete picture of the perioperative complications, this entire original group was analyzed. Of the 114 patients, seven (eight hips) died within two years (range, five to twenty-two months) after the surgery. None of these patients died of causes related to the hip surgery. Additionally, seventeen patients (eighteen hips) died more than two years postoperatively but had not returned for follow-up. Five hips were lost to follow-up. Thus, eighty-six patients (ninety-two hips) were available for review at two to eleven years (mean, five years) after the operation (Table I). (One patient with bilateral total hip replacement was followed for more than two years on only one side.) There was no significant difference regarding age (p = 0.95; t test), side (p = 0.28; chi-square test), or preoperative Charnley pain or function score (p = 0.78 and p = 0.72, respectively; chi-square test) between the twenty-nine patients (thirty-one hips) followed for less than two years (died or lost to follow-up) and the eighty-six patients (ninety-two hips) followed for two years or more. The only difference was that there were more men in the group followed for less than two years (p = 0.01; chi-square test).
    The cementless acetabular component was the Universal cup I (Biomet, Warsaw, Indiana), which is a hemispherical ­titanium-alloy component with a plasma-spray coating. The peripheral flange has a flare to provide a press-fit. The plasma-spray coating increases the outer diameter by 1 mm compared with the reamed diameter, thereby further enhancing stability. The cup liner is a cylindrical shell with both standard and high-wall options. The technique for insertion of the acetabular cup included routine use of titanium screws inserted through the dome for supplemental fixation.
    The cementless femoral component was the Taperloc femoral stem (Biomet). This component is composed of titanium alloy with a circumferential plasma-spray coating on its proximal third. It is a collarless, tapered, wedge-shaped implant and is available with a lateral-offset option. Insertion of the femoral component requires no endosteal reaming. Broaching achieves a solid cortical press-fit. The broach is used as a trial to check for stability and leg length. The permanent implant is then inserted with firm impaction. Stability of the prosthesis is manually tested by twisting the screwed-in handle used for insertion of the prosthesis. Excellent intraoperative stability was perceived in every patient, despite variation in bone stock.
    All patients were instructed to bear approximately 10% of their weight on the treated extremity for six weeks, at which time they were advanced to a cane. A low-dose warfarin protocol was used, with 10 mg given on the night of the surgery and the dose subsequently adjusted daily to maintain the prothrombin time at fifteen seconds.
    Objective preoperative and follow-up evaluation was performed by specially trained physical therapists or research fellows. Clinical evaluations were performed preoperatively, at six weeks postoperatively, and then yearly with use of the Charnley modification of the Merle d’Aubigné and Postel scale17. The Harris hip-scoring system18 was incorporated into the clinical evaluation at our institution later in the study period, so a preoperative Harris hip score was not available for seventeen of the ninety-two hips. The patient was questioned specifically about thigh or groin pain, which was recorded as present or absent.
    Leg-holders were used to position the limb accurately for sequential radiographic review, and the distance between the film and the x-ray tube was constant. The quality of the bone stock preoperatively was categorized radiographically with the method described by Dorr et al.19. Subsidence of the femoral component was defined as a change in position of more than 3 mm. All changes around the cementless femoral component were documented with a modification of the system suggested by Engh et al.20-22. The femoral component was classified as stable with bone ingrowth, stable with fibrous ingrowth, or unstable. Mechanical failure was deemed to have occurred if the femoral component was revised for loosening or was considered to be radiographically unstable.
    The position of the acetabular component was determined according to the criteria of Massin et al.23. Any change in component position of either 3 mm or 3° was considered to represent migration of the cup, a definite sign of cup-loosening24. Radiolucency of greater than 1 mm in thickness at the component-bone interface was looked for in the three zones defined by DeLee and Charnley25. Cup wear was assessed according to the technique of Livermore et al.26. Briefly, the shortest distance between the center of the femoral head and the edge of the metal cup was used for this evaluation. Each radiograph was measured by a single observer to the nearest 0.25 mm with use of the X-caliper (Eisenlohr Technologies, Davis, California). This is an electronic caliper that automatically corrects for magnification on the basis of a known variable such as the actual femoral head size.

    Statistical Analysis

    Categorical variables were analyzed with use of a chi-square test27. Statistical comparison to test for differences between two groups was performed with the Student t test for uncorrelated means27. All analysis was done with StatView 5.0 (SAS Institute, Cary, North Carolina).

    Clinical Results

    There was substantial improvement in pain relief, function, and motion following the total hip arthroplasties. At the last follow-up evaluation, the mean Harris hip score was 82 ± 13 points (range, 49 to 100 points). The Harris hip score was not determined for six patients (six hips) at the last office visit: two of them had died, and we were unable to contact the remaining four by telephone or letter. According to information recorded in the office charts, four of these six patients reported no pain, one had slight pain with tenderness over the greater trochanter, and one had moderate pain over an ununited greater trochanter. Neither of the latter two patients had radiographic signs of loosening of the prosthesis. As previously mentioned, because the Harris hip score was not incorporated into the clinical evaluation in the beginning of this study, preoperative scores were available for only seventy-five of the ninety-two hips; the mean score for these seventy-five hips was 40 13 points (range, 15 to 78 points). The sixty-nine hips with both preoperative and postoperative Harris hip scores had a mean increase of 42 points.
    The mean Charnley score for pain improved from 2.7 points (2, 3, or 4 points) preoperatively to 5.7 points (range, 3 to 6 points) at the time of the latest follow-up, the mean score for function improved from 2.8 points (range, 1 to 5 points) to 4.2 points (range, 1 to 6 points), and the mean score for motion improved from 4.0 points (range, 2 to 6 points) to 5.2 points (4, 5, or 6 points). Of the ninety-two hips, 77% (seventy-one) were not considered to be painful by the patients and 17% (sixteen) were considered to be mildly painful without limitation of activity. Four (4%) of the hips were associated with pain in the thigh. Each of these patients had radiographic evidence of osseous ingrowth, and each had a Charnley pain score of 5 points. Five (5%) of the ninety-two hips had pain that was considered limiting, and the location of the limiting pain was described as the groin (one hip), buttock (one hip), or trochanter (three hips).
    At the time of the most recent follow-up, the eighty patients (eighty-six hips) with an available postoperative Harris hip score were evaluated with regard to whether they could walk six blocks or more without an assistive device (24% [twenty-one] of the eighty-six hips); could walk six blocks or more with support (10% [nine] of the hips); could walk outdoors for a distance of less than six blocks (31% [twenty-seven]), either with support (nineteen) or without support (eight); could walk only indoors (31% [twenty-seven]); or could not walk because of medical conditions unrelated to the hip surgery (2% [two, neither of which was painful]). They were also evaluated with regard to whether they required a walker for walking (20% [seventeen]), had difficulty putting on shoes and socks (43% [thirty-seven]), and could ascend and descend stairs (86% [seventy-four]).
    There were no femoral or acetabular revisions.

    Radiographic Results

    Of the ninety-two hips that were evaluated after at least two years, 85% (seventy-eight) were followed radiographically for two years or more (mean, five years; range, two to ten years). Eleven hips were followed for less than two years, and we were unable to find the follow-up radiographs for three hips.
    The acetabular cup angle averaged 42° (range, 27° to 60°). No socket demonstrated migration (definite loosening), and none showed complete bone-prosthesis lucency consistent with probable loosening.
    Wear was measured on the immediate postoperative radiograph and on radiographs made at the time of the most recent follow-up. These radiographs were available for seventy-three of the seventy-eight hips. Of these, 41% (thirty) had a 22-mm femoral head and 59% (forty-three) had a 28-mm head. Forty-three percent (thirteen) of the thirty 22-mm sockets and 40% (seventeen) of the forty-three 28-mm sockets demonstrated measurable wear. Linear cup wear averaged 0.076 mm/yr for the hips with a 22-mm femoral head and 0.074 mm/yr for those with a 28-mm head. Volumetric wear was 29 and 46 mm3/yr, respectively. Acetabular lysis was seen in 4% (three) of the seventy-eight hips; two had a 22-mm head and one, a 28-mm head.
    According to the system of Dorr et al.19, 17% (fifteen) of the ninety hips in which bone type was evaluated had type-A cortical bone; 58% (fifty-two), type-B; and 26% (twenty-three), type-C. Two hips did not have available radiographs for this evaluation. The clinical results were independent of bone type. According to the classification system of Engh et al.20, all of the femoral components had radiographic evidence of bone ingrowth. No component was unstable, and no fibrous ingrowth was seen. None of these cementless femoral components had evidence of mechanical failure (that is, either a revision or radiographic evidence of failure) at a mean of five years (range, two to eleven years) after the arthroplasty. Despite the high prevalence of polyethylene wear and the presence of acetabular osteolysis, there was only one case of femoral osteolysis. This osteolysis was localized at the proximal-medial aspect of the femoral neck, proximal to the coating of the prosthesis.

    Complications

    In the original group of 123 hips, the rate of medical complications was 24% (thirty hips). The complications included femoral nerve palsy (associated with one hip [0.8%]), with total recovery by six months; urinary tract infection (five hips [4.1%]); pulmonary emboli (eight hips [6.5%]), none of which were symptomatic and all of which were detected on routine postoperative lung scans; cardiac abnormalities (three hips [2.4%]), consisting of one case of congestive heart failure, one case of angina, and one case of atrial fibrillation; gout attack (three hips [2.4%]); intestinal ileus (three hips [2.4%]); peptic ulcer (one hip [0.8%]); seizure (one hip [0.8%]); urinary retention (six hips [4.9%]); and enterocolitis (two hips [1.6%]). It is important to note that there were no perioperative deaths. Equally important are the results involving peri­operative component-related complications. There were no femoral fractures, dislocations, or infections. One patient did eventually have recurrent dislocations (a total of nine dislocations treated by closed reduction) but declined operative intervention. Two patients sustained a periprosthetic fracture at 1.5 and six years postoperatively. Both fractures were related to a fall. One was treated with traction, and the other was treated with open reduction and internal fixation.
    We are not aware of any other reports in the literature on the efficacy of primary cementless total hip arthroplasty in octogenarians. There are a few related reports on the use of cementless total hip arthroplasty in older patients. Engh et al.22 reported good results with the use of the AML prosthesis (DePuy, Warsaw, Indiana) in patients older than sixty-five years. Survivorship probabilities with revision and mechanical failure as the end points were 98.6% and 92.5%, respectively, at eight years. There were three stem revisions, one because of stem breakage and two because of failure of biologic stabilization. The rate of revision because of failed biologic stabilization was only 0.6% at a mean of six years. McAuley et al.28 reported a cumulative probability of prosthetic survival of 0.92 at twelve years, with any reoperation as the end point, in patients sixty-five years of age or older who were treated with different designs of the AML femoral component and a fully porous-coated acetabular component. The survival rate for the femoral component was 0.97, and that for the acetabular component was 0.92. At a mean of 8.5 years, 91% (139) of the 152 patients reported no or mild pain and had a normal activity level.
    Concerns regarding cementless total hip arthroplasty in the elderly include persistent pain, failure of bone ingrowth, and cost6,8,9,29,30. Our data indicate no clinically adverse consequences of cementless fixation in terms of pain and function. Even patients with thigh pain had satisfactory clinical scores, and all patients had radiographic evidence of bone ingrowth. The decreased time required for insertion of an uncemented prosthesis in this physiologically frail age-group is an advantage over arthroplasty with cement. The time saved by avoiding curing of femoral and acetabular cement mantles decreases blood loss and operative time. Fat embolism is a well documented consequence of cement injection and pres­surization11-13. Patterson et al.31 reported seven cases of cardiac arrest during total hip replacement with cement and a long-stem femoral component. Three patients were successfully resuscitated, but four patients died. Factors that were common to all of these patients were advanced age, a previously undisturbed intramedullary canal, and osteo­porotic bone. Cementless fixation is likely to reduce the chance of this serious complication.
    Many authors9,32 have based implant selection on an arbitrary age and bone quality because of the belief that initial implant stability may not be achievable in the elderly. In our series, no prosthesis was thought to be unstable when tested manually during surgery. Failure due to a lack of osseointegration is also of concern in these patients. There were no instances of loosening after a minimum two-year follow-up period in our patients. Therefore, we concluded that the bone of elderly patients can provide adequate initial stability for cementless implants, leading to subsequent bone ingrowth.
    Cemented total hip components generally are considered to be a less expensive and therefore a more appropriate option for the elderly. The cost of the prosthesis alone is the usual basis of comparison, even though many additional costs are incurred in the implantation of a cemented stem and cup. For example, longer operative time as well as the cement, cement-mixing setup, cement pressurizers, cement restrictors, pulse irrigation, and cement guns are all associated with costs. Barrack et al.33 examined the costs of total hip replacement with a cemented or uncemented stem and found the actual cost for a modern cemented stem to be greater than that for an uncemented stem.
    Persons eighty years of age or older are, by percentage, the fastest growing segment of the American population, with their number estimated to increase to nine million by the year 2000 and to thirty-two million by the year 205034. Because of their longevity, even this elderly group may require between ten and twenty years of service from their implants35.
    In conclusion, in the short term, cementless fixation for total hip replacement in octogenarians can decrease pain and improve function. Long-term biologic fixation may prove to be of benefit as these individuals lead longer and more active lives.
    Boettcher WG: Total hip arthroplasties in the elderly. Morbidity, mortality, and cost effectiveness. Clin Orthop,1992.274: 30-4, 27430  1992  [PubMed]
     
    Brander VA; Malhotra S; Jet J; Heinemann AW; and Stulberg SD: Outcome of hip and knee arthroplasty in persons aged 80 years and older. Clin Orthop,1997.345: 67-78, 34567  1997  [PubMed]
     
    Ekelund A; Rydell N; and Nilsson OS: Total hip arthroplasty in patients 80 years of age and older. Clin Orthop,1992.281: 101-6, 281101  1992  [PubMed]
     
    Levy RN; Levy CM; Snyder J; and Digiovanni J: Outcome and long-­term results following total hip replacement in elderly patients. Clin Orthop. ,1995.316: 25-30, 31625  1995  [PubMed]
     
    Pettine KA; Aamlid BC; and Cabanela ME: Elective total hip arthroplasty in patients older than 80 years of age. Clin Orthop,1991.266: 127-32, 266127  1991  [PubMed]
     
    Dorr LD; Wan Z; and Gruen T: Functional results in total hip replacement in patients 65 years and older. Clin Orthop ,1997.336: 143-51, 336143  1997  [PubMed]
     
    Grecula MJ; Grigoris P; Brown I; Dorey F; and Amstutz HC: The durability of cemented total hip arthroplasty in patients over sixty: a fifteen year survivorship analysis. Orthop Trans,1994.18: 875-6, 18875  1994 
     
    Healy WL: Economic considerations in total hip arthroplasty and implant standardization. Clin Orthop ,1995.311: 102-8, 311102  1995  [PubMed]
     
    Wixson RL; Stulberg SD; and Mehlhoff M: Total hip replacement with cemented, uncemented, and hybrid prostheses. A comparison of clinical and radiographic results at two to four years. J Bone Joint Surg Am,1991.73: 257-70, 73257  1991  [PubMed]
     
    Alexander JP, and Barron DW: Biochemical disturbances associated with total hip replacement. J Bone Joint Surg Br ,1979.61: 101-6, 61101  1979  [PubMed]
     
    Christie J; Burnett R; Potts HR; and Pell AC: Echocardiography of transatrial embolism during cemented and uncemented hemiarthroplasty of the hip. J Bone Joint Surg Br ,1994.76: 409-12, 76409  1994  [PubMed]
     
    Orsini EC; Byrick RJ; Mullen JB; Kay JC; and Waddell JP: Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components. The role of intramedullary pressure. J Bone Joint Surg Am,1987.69: 822-32, 69822  1987  [PubMed]
     
    Pitto RP; Koessler M; and Draenert K: Prophylaxis of fat and bone marrow embolism in cemented total hip arthroplasty. Clin Orthop,1998.355: 23-34, 35523  1998  [PubMed]
     
    Ries MD; Lynch F; Rauscher LA; Richman J; Mick C; and Gomez M: Pulmonary function during and after total hip replacement. Findings in patients who have insertion of a femoral component with and without cement. J Bone Joint Surg Am,1993.75: 581-7, 75581  1993  [PubMed]
     
    Arroyo JS; Garvin KL; and McGuire MH: Fatal marrow embolization following a porous-coated bipolar hip endoprosthesis. J Arthroplasty,1994.9: 449-52, 9449  1994  [PubMed]
     
    Hofmann S; Hopf R; Mayr G; Schlag G; and Salzer M: In vivo femoral intra­medullary pressure during uncemented hip arthroplasty. Clin Orthop ,1999.360: 136-46, 360136  1999  [PubMed]
     
    Charnley J: The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg Br,1972.54: 61-76, 5461  1972  [PubMed]
     
    Harris WH: Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am,1969.51: 737-55, 51737  1969  [PubMed]
     
    Dorr LD, Faugere MC, Mackel AM, Gruen TA, Bognar B, Malluche HH.: Structural and cellular assessment of bone quality of proximal femur. Bone. ,1993.14: 231-42, 14231  1993  [PubMed]
     
    Engh CA; Bobyn JD; and Glassman AH: Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br,1987.69: 45-55, 6945  1987  [PubMed]
     
    Engh CA, and Massin P: Cementless total hip arthroplasty using the anatomic medullary locking stem. Results using a survivorship analysis. Clin Orthop,1989.249: 141-58, 249141  1989  [PubMed]
     
    Engh CA; Glassman AH; and Suthers KE: The case for porous-coated hip implants. The femoral side. Clin Orthop ,1990.261: 63-81, 26163  1990  [PubMed]
     
    Massin P; Schmidt L; and Engh CA: Evaluation of cementless acetabular component migration. An experimental study. J Arthroplasty ,1989.4: 245-51, 4245  1989  [PubMed]
     
    Hodgkinson JP; Shelley P; and Wroblewski BM: The correlation between the roentgenographic appearance and operative findings at the bone-cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop,1988.228: 105-9, 228105  1988  [PubMed]
     
    DeLee JG, and Charnley J: Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop,1976.121: 20-32, 12120  1976  [PubMed]
     
    Livermore J; Ilstrup D; and Morrey B: Effect of femoral head size on wear of the polyethylene acetabular component. J Bone Joint Surg Am,1990.72: 518-28, 72518  1990  [PubMed]
     
    Daniel WW. Biostatistics: a foundation for analysis in the health sciences. 5th ed. New York: Wiley; 1991 
     
    McAuley JP; Moore KD; Culpepper WJ 2d; and Engh CA: Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older. J Bone Joint Surg Am,1998.80: 1648-55, 801648  1998  [PubMed]
     
    Barrack RL.: Implant matching has no clinical or scientific basis. J Arthroplasty. ,1996.11: 969-72, 11969  1996  [PubMed]
     
    Maloney WJ, and Harris WH: Comparison of a hybrid with an uncemented total hip replacement. A retrospective matched-pair study. J Bone Joint Surg Am,1990.72: 1349-52, 721349  1990  [PubMed]
     
    Patterson BM; Healey JH; Cornell CN; and Sharrock NE: Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am.,1991.73: 271-7, 73271  1991  [PubMed]
     
    Harris WH, and Davies JP: Modern use of modern cement for total hip replacement. Orthop Clin North Am,1988.19: 581-9, 19581  1988  [PubMed]
     
    Barrack RL; Castro F; and Guinn S: Cost of implanting a cemented versus cementless femoral stem. J Arthroplasty,1996.11: 373-6, 11373  1996  [PubMed]
     
    US Bureau of the Census. http://www.census.gov/population/projections/nation/summary/np-t4-a.pdf, http://www.census.gov/population/projections/nation/summary/np-t4-g. pdf, and http://www.census.gov/prod/1/pop/p25-1130/p251130g.pdf, Table B-1. Accessed Jan 15, 2000 
     
    Ritter MA; Albohm MJ; Keating EM; Faris PM; and Meding JB: Life expectancy after total hip arthroplasty. J Arthroplasty,1998.13: 874-5, 13874  1998  [PubMed]
     

    Submit a comment

    Topics

    Anchor for JumpAnchor for JumpTABLE I:  Demographic Characteristics
    No. of hips92
    No. of patients86
    Mean duration of follow-up (range) (yr)?5 (2-11)
    Mean age (range) (yr)83 (80-89)
    Mean weight (range) (kg)68 (49-109)
    Gender (M/F) (no. of hips)32/60
    Initial diagnosis (no. of hips)
    Osteoarthritis91
    Avascular necrosis?1
    Charnley class (% of hips)
    A54
    B39
    C?7
    Boettcher WG: Total hip arthroplasties in the elderly. Morbidity, mortality, and cost effectiveness. Clin Orthop,1992.274: 30-4, 27430  1992  [PubMed]
     
    Brander VA; Malhotra S; Jet J; Heinemann AW; and Stulberg SD: Outcome of hip and knee arthroplasty in persons aged 80 years and older. Clin Orthop,1997.345: 67-78, 34567  1997  [PubMed]
     
    Ekelund A; Rydell N; and Nilsson OS: Total hip arthroplasty in patients 80 years of age and older. Clin Orthop,1992.281: 101-6, 281101  1992  [PubMed]
     
    Levy RN; Levy CM; Snyder J; and Digiovanni J: Outcome and long-­term results following total hip replacement in elderly patients. Clin Orthop. ,1995.316: 25-30, 31625  1995  [PubMed]
     
    Pettine KA; Aamlid BC; and Cabanela ME: Elective total hip arthroplasty in patients older than 80 years of age. Clin Orthop,1991.266: 127-32, 266127  1991  [PubMed]
     
    Dorr LD; Wan Z; and Gruen T: Functional results in total hip replacement in patients 65 years and older. Clin Orthop ,1997.336: 143-51, 336143  1997  [PubMed]
     
    Grecula MJ; Grigoris P; Brown I; Dorey F; and Amstutz HC: The durability of cemented total hip arthroplasty in patients over sixty: a fifteen year survivorship analysis. Orthop Trans,1994.18: 875-6, 18875  1994 
     
    Healy WL: Economic considerations in total hip arthroplasty and implant standardization. Clin Orthop ,1995.311: 102-8, 311102  1995  [PubMed]
     
    Wixson RL; Stulberg SD; and Mehlhoff M: Total hip replacement with cemented, uncemented, and hybrid prostheses. A comparison of clinical and radiographic results at two to four years. J Bone Joint Surg Am,1991.73: 257-70, 73257  1991  [PubMed]
     
    Alexander JP, and Barron DW: Biochemical disturbances associated with total hip replacement. J Bone Joint Surg Br ,1979.61: 101-6, 61101  1979  [PubMed]
     
    Christie J; Burnett R; Potts HR; and Pell AC: Echocardiography of transatrial embolism during cemented and uncemented hemiarthroplasty of the hip. J Bone Joint Surg Br ,1994.76: 409-12, 76409  1994  [PubMed]
     
    Orsini EC; Byrick RJ; Mullen JB; Kay JC; and Waddell JP: Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components. The role of intramedullary pressure. J Bone Joint Surg Am,1987.69: 822-32, 69822  1987  [PubMed]
     
    Pitto RP; Koessler M; and Draenert K: Prophylaxis of fat and bone marrow embolism in cemented total hip arthroplasty. Clin Orthop,1998.355: 23-34, 35523  1998  [PubMed]
     
    Ries MD; Lynch F; Rauscher LA; Richman J; Mick C; and Gomez M: Pulmonary function during and after total hip replacement. Findings in patients who have insertion of a femoral component with and without cement. J Bone Joint Surg Am,1993.75: 581-7, 75581  1993  [PubMed]
     
    Arroyo JS; Garvin KL; and McGuire MH: Fatal marrow embolization following a porous-coated bipolar hip endoprosthesis. J Arthroplasty,1994.9: 449-52, 9449  1994  [PubMed]
     
    Hofmann S; Hopf R; Mayr G; Schlag G; and Salzer M: In vivo femoral intra­medullary pressure during uncemented hip arthroplasty. Clin Orthop ,1999.360: 136-46, 360136  1999  [PubMed]
     
    Charnley J: The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg Br,1972.54: 61-76, 5461  1972  [PubMed]
     
    Harris WH: Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am,1969.51: 737-55, 51737  1969  [PubMed]
     
    Dorr LD, Faugere MC, Mackel AM, Gruen TA, Bognar B, Malluche HH.: Structural and cellular assessment of bone quality of proximal femur. Bone. ,1993.14: 231-42, 14231  1993  [PubMed]
     
    Engh CA; Bobyn JD; and Glassman AH: Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br,1987.69: 45-55, 6945  1987  [PubMed]
     
    Engh CA, and Massin P: Cementless total hip arthroplasty using the anatomic medullary locking stem. Results using a survivorship analysis. Clin Orthop,1989.249: 141-58, 249141  1989  [PubMed]
     
    Engh CA; Glassman AH; and Suthers KE: The case for porous-coated hip implants. The femoral side. Clin Orthop ,1990.261: 63-81, 26163  1990  [PubMed]
     
    Massin P; Schmidt L; and Engh CA: Evaluation of cementless acetabular component migration. An experimental study. J Arthroplasty ,1989.4: 245-51, 4245  1989  [PubMed]
     
    Hodgkinson JP; Shelley P; and Wroblewski BM: The correlation between the roentgenographic appearance and operative findings at the bone-cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop,1988.228: 105-9, 228105  1988  [PubMed]
     
    DeLee JG, and Charnley J: Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop,1976.121: 20-32, 12120  1976  [PubMed]
     
    Livermore J; Ilstrup D; and Morrey B: Effect of femoral head size on wear of the polyethylene acetabular component. J Bone Joint Surg Am,1990.72: 518-28, 72518  1990  [PubMed]
     
    Daniel WW. Biostatistics: a foundation for analysis in the health sciences. 5th ed. New York: Wiley; 1991 
     
    McAuley JP; Moore KD; Culpepper WJ 2d; and Engh CA: Total hip arthroplasty with porous-coated prostheses fixed without cement in patients who are sixty-five years of age or older. J Bone Joint Surg Am,1998.80: 1648-55, 801648  1998  [PubMed]
     
    Barrack RL.: Implant matching has no clinical or scientific basis. J Arthroplasty. ,1996.11: 969-72, 11969  1996  [PubMed]
     
    Maloney WJ, and Harris WH: Comparison of a hybrid with an uncemented total hip replacement. A retrospective matched-pair study. J Bone Joint Surg Am,1990.72: 1349-52, 721349  1990  [PubMed]
     
    Patterson BM; Healey JH; Cornell CN; and Sharrock NE: Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am.,1991.73: 271-7, 73271  1991  [PubMed]
     
    Harris WH, and Davies JP: Modern use of modern cement for total hip replacement. Orthop Clin North Am,1988.19: 581-9, 19581  1988  [PubMed]
     
    Barrack RL; Castro F; and Guinn S: Cost of implanting a cemented versus cementless femoral stem. J Arthroplasty,1996.11: 373-6, 11373  1996  [PubMed]
     
    US Bureau of the Census. http://www.census.gov/population/projections/nation/summary/np-t4-a.pdf, http://www.census.gov/population/projections/nation/summary/np-t4-g. pdf, and http://www.census.gov/prod/1/pop/p25-1130/p251130g.pdf, Table B-1. Accessed Jan 15, 2000 
     
    Ritter MA; Albohm MJ; Keating EM; Faris PM; and Meding JB: Life expectancy after total hip arthroplasty. J Arthroplasty,1998.13: 874-5, 13874  1998  [PubMed]
     
    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Hip
    Related Audio and Videos
    PubMed Articles
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    12/22/2011
    VA - Charleston Area Medical Center
    12/22/2011
    ME - Central Maine Medical Center